Gynecology & Obstetrics (all articles)
Expert Consensus: Topical treatment of recurrent vulvovaginal candidiasis.
29 Apr, 2022 | 10:46h | UTC
Study Commentary | Mesh surgery for prolapse: complications are uncommon.
29 Apr, 2022 | 08:19h | UTC
Phase 2b trial: Prefusion F protein–based respiratory syncytial virus immunization in pregnancy.
28 Apr, 2022 | 08:09h | UTCPrefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: RSV Prefusion F Protein-Based Immunization Studied in Pregnancy – HealthDay
Commentary on Twitter
In pregnant women, RSVpreF vaccine elicited neutralizing antibody responses with efficient transplacental transfer and without evident safety concerns. https://t.co/r8oktZmBZQ pic.twitter.com/UE7ffxYJW6
— NEJM (@NEJM) April 27, 2022
Clinical Review: Diagnosis and management of covid-19 in pregnancy.
27 Apr, 2022 | 08:13h | UTCDiagnosis and management of covid-19 in pregnancy – The BMJ
Guideline: First trimester examination of fetal anatomy.
27 Apr, 2022 | 08:02h | UTC
Obesity and risk of female reproductive conditions: A Mendelian randomization study.
27 Apr, 2022 | 01:31h | UTCObesity and risk of female reproductive conditions: A Mendelian randomisation study – PLOS Medicine
News Release: Obesity may increase risk of some female reproductive disorders – PLOS
Practice Pointer: Making decisions about radiological imaging in pregnancy.
26 Apr, 2022 | 08:44h | UTCMaking decisions about radiological imaging in pregnancy – The BMJ
RCT: Uterine artery embolization vs. myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy.
26 Apr, 2022 | 08:08h | UTC
Progesterone, cervical cerclage or cervical pessary to prevent preterm birth: a decision-making analysis of international guidelines.
26 Apr, 2022 | 07:30h | UTC
Cohort Study: COVID-19 vaccination during early pregnancy was not associated with increased risk of congenital fetal anomalies.
25 Apr, 2022 | 00:59h | UTCCommentaries:
COVID vaccine in early pregnancy not tied to birth defects – CIDRAP
No Sign That COVID Vaccine in Pregnancy Raises Birth Defect Risk – HealthDay
UK drug regulator advises patients and doctors against the use of Pregabalin during pregnancy due to a possible increased risk of congenital malformations.
22 Apr, 2022 | 09:31h | UTCSee also: Pregabalin and risks in pregnancy – Medicines and Healthcare products Regulatory Agency
Source: Avoid prescribing pregabalin during pregnancy if possible, says UK drug regulator – The BMJ ($)
Commentary on Twitter
The Medicines and Healthcare Products Regulatory Agency (@MHRAgovuk) has strengthened its warning about avoiding pregabalin during pregnancy after new data showed an increased risk of major congenital malformations associated with the drug https://t.co/ghGvqCqA0C
— The BMJ (@bmj_latest) April 22, 2022
Vitamin D supplements in pregnancy: what’s the latest evidence?
21 Apr, 2022 | 09:58h | UTCVitamin D supplements in pregnancy: what’s the latest evidence? – Evidently Cochrane Blog
Original Study: Vitamin D supplementation for women during pregnancy – Cochrane Library
USPSTF Draft Statement: Postmenopausal women should not use hormone therapy to prevent chronic health problems.
20 Apr, 2022 | 10:15h | UTCDraft Recommendation Statement: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons – U.S. Preventive Services Task Force
Commentary: USPSTF Advises Against Hormone Therapy to Prevent Chronic Conditions – HealthDay
Studies highlight meningitis vaccine’s potential against gonorrhea.
20 Apr, 2022 | 10:06h | UTCCommentary: Studies highlight meningitis vaccine’s potential against gonorrhea – CIDRAP
News Release: Threat of untreatable gonorrhoea could be tackled using an existing meningitis vaccine – The Lancet
Study 1: Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study – The Lancet Infectious Diseases (link to abstract – $ for full-text)
Study 2: Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study – The Lancet Infectious Diseases (link to abstract – $ for full-text)
FDA warns of risks associated with non-invasive prenatal screening tests – inappropriate interpretation of results may lead to potentially improper medical decisions.
20 Apr, 2022 | 09:52h | UTC
ASCO Guideline Update: biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer.
20 Apr, 2022 | 09:47h | UTC
Cohort Study: Infertility in women linked to increased risk of heart failure with preserved ejection fraction.
20 Apr, 2022 | 09:44h | UTCInfertility and Risk of Heart Failure in the Women’s Health Initiative – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Podcast: Infertility and Risk of Heart Failure in the Women’s Health Initiative
Commentaries:
Infertility in Women Linked to Subsequent Risk of HFpEF – TCTMD
MGH study finds infertility associated with increased risk of heart failure – MedicalResearch
National, regional, and global estimates of anemia by severity in women and children for 2000–19.
20 Apr, 2022 | 09:25h | UTCInvited Commentary: Sustainable Development Goals for anaemia: 20 years later, where are we now? – The Lancet Global Health
M-A: Invasive group A streptococcal disease in pregnant women and young children.
20 Apr, 2022 | 09:05h | UTCInvited Commentary: Recognising group A streptococcal disease in pregnancy – The Lancet Infectious Diseases (free registration required)
Review: Preterm premature rupture of membranes – inpatient versus outpatient management.
20 Apr, 2022 | 09:06h | UTC
Systematic Review: Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.
20 Apr, 2022 | 09:03h | UTC
Endocrine therapies for breast and prostate cancers: Essentials for primary care.
19 Apr, 2022 | 01:14h | UTC
Advanced testing for human papillomavirus infection improves prognostic evaluation in cervical cancer.
18 Apr, 2022 | 09:33h | UTCHuman Papillomavirus Infection Determines Prognosis in Cervical Cancer – Journal of Clinical Oncology (link to abstract – $ for full-text)
Commentary: Study Confirms Favorable Prognosis for HPV-Positive Cervical Cancer— RNA sequencing identified more HPV+ tumors, showed 43% mortality disparity for HPV- tumors – MedPage Today (free registration required)
Discharge preparation and readiness after birth: a scoping review of global policies, guidelines and literature.
14 Apr, 2022 | 08:07h | UTCRelated:
WHO recommendations on maternal and newborn care for a positive postnatal experience.
Putting positive experiences at the center of postnatal care.
Review | Breast MRI during pregnancy and lactation: clinical challenges and technical advances.
14 Apr, 2022 | 07:57h | UTC